Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Plos One|August 1, 2012
qPMS7: a fast algorithm for finding (ℓ, d)-motifs in DNA and protein sequencesHieu Dinh, Sanguthevar Rajasekaran, Jaime Davila
IEEE/ACM Transactions on Computational Biology and Bioinformatics|November 3, 2007
Fast and practical algorithms for planted (l, d) motif searchJaime Davila, Sudha Balla, Sanguthevar Rajasekaran
BMC Medical Genomics|March 2, 2021
Determining mutational burden and signature using RNA-seq from tumor-only samplesErik Jessen, Yuanhang Liu, Jaime Davila, et al.
Plant Physiology|February 9, 2010
Extensive rearrangement of the Arabidopsis mitochondrial genome elicits cellular conditions for thermotoleranceVikas Shedge, Jaime Davila, Maria P Arrieta-Montiel, et al.
Genetics|October 14, 2009
Diversity of the Arabidopsis mitochondrial genome occurs via nuclear-controlled recombination activityMaria P Arrieta-Montiel, Vikas Shedge, Jaime Davila, et al.
American Journal of Clinical Pathology|October 5, 2022
Transcriptomic Analysis of Cirrhosis-Like Hepatocellular Carcinoma Reveals Distinct Molecular Characteristics and Pathologic Staging ImplicationsBenjamin J Van Treeck, Roger K Moreira, Taofic Mounajjed, et al.
Genes, Chromosomes & Cancer|September 4, 2013
Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphomaAndrew L Feldman, George Vasmatzis, Yan W Asmann, et al.
Diagnostic Pathology|April 28, 2019
Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal womanAlessandra J Ainsworth, Nooshin K Dashti, Taofic Mounajjed, et al.
Translational Oncology|June 3, 2026
RNA-Based and DNA-Based Next-Generation Sequencing of KIT and PDGFRA Mutations in Gastrointestinal Stromal Tumors: Analytical Performance and Epidemiologic InsightsSoumya Jaladi, Saba Alvand, Beth A Pitel, et al.
Ophthalmology and Therapy|April 23, 2018
A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle GlaucomaFrancisco Gómez-Aguayo, José A Paczka, Rubén Leñero-Córdova, et al.
Pageof 2